Name | (E)-but-2-enedioic acid,N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine |
---|---|
Synonyms |
Saracatinib difumarate
N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)-4-quinazolinamine (2E)-2-butenedioate (1:2) UNII-8R1DYT4EAW AZD-0530 difumarate 4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2) |
Description | Saracatinib (AZD0530) difumarate is a potent Src inhibitor with IC50 values of 2.7-11 nM for c-Src, Lck, c-YES, Lyn, Fyn, Fgr and Blk, and is selective for other tyrosine kinases. [1]. |
---|---|
Related Catalog | |
Target |
IC50: 2.7 nM (Src), 30 nM (v-Abl), 66 nM (EGFR), 200 nM (c-Kit)[1] |
References |
Molecular Formula | C35H40ClN5O13 |
---|---|
Molecular Weight | 774.171 |
Exact Mass | 773.231140 |
PSA | 239.64000 |
LogP | 3.31190 |